How to buy Abeona Therapeutics stock
Learn how to easily invest in Abeona Therapeutics stock.
Abeona Therapeutics is a biotechnology business based in the US. Abeona Therapeutics shares (ABEO) are listed on the NASDAQ and all prices are listed in US Dollars. Abeona Therapeutics employs 57 staff and has a trailing 12-month revenue of around $3.6 million.
How to buy Abeona Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ABEO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Abeona Therapeutics stock price (NASDAQ: ABEO)Use our graph to track the performance of ABEO stocks over time.
Abeona Therapeutics shares at a glance
|Latest market close||$3.66|
|52-week range||$2.19 - $5.80|
|50-day moving average||$3.71|
|200-day moving average||$3.24|
|Wall St. target price||$20.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.94|
Buy Abeona Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Abeona Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Abeona Therapeutics price performance over time
|1 week (2023-09-20)||-3.68%|
|1 month (2023-08-25)||-6.87%|
|3 months (2023-06-27)||-21.63%|
|6 months (2023-03-27)||34.56%|
|1 year (2022-09-27)||22.00%|
|2 years (2021-09-27)||210.17%|
|3 years (2020-09-25)||96.77%|
|5 years (2018-09-27)||13|
Abeona Therapeutics financials
|Revenue TTM||$3.6 million|
|Gross profit TTM||$-28,001,000|
|Return on assets TTM||-57.27%|
|Return on equity TTM||-267.17%|
|Market Capitalization||$90.6 million|
TTM: trailing 12 months
Abeona Therapeutics share dividends
We're not expecting Abeona Therapeutics to pay a dividend over the next 12 months.
Have Abeona Therapeutics's shares ever split?
Abeona Therapeutics's shares were split on a 1:25 basis on 4 July 2022. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Abeona Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Abeona Therapeutics shares which in turn could have impacted Abeona Therapeutics's share price.
Abeona Therapeutics share price volatility
Over the last 12 months, Abeona Therapeutics's shares have ranged in value from as little as $2.19 up to $5.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abeona Therapeutics's is 1.2794. This would suggest that Abeona Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Abeona Therapeutics overview
Abeona Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc.
Abeona Therapeutics in the news
Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa
3 Biotech Blockbusters to Turn $5,000 Into $50,000
Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer
Frequently asked questionsWhat percentage of Abeona Therapeutics is owned by insiders or institutions?
Currently 6.729% of Abeona Therapeutics shares are held by insiders and 43.665% by institutions. How many people work for Abeona Therapeutics?
Latest data suggests 57 work at Abeona Therapeutics. When does the fiscal year end for Abeona Therapeutics?
Abeona Therapeutics's fiscal year ends in December. Where is Abeona Therapeutics based?
Abeona Therapeutics's address is: 1330 Avenue of the Americas, New York, NY, United States, 10019 What is Abeona Therapeutics's ISIN number?
Abeona Therapeutics's international securities identification number is: US00289Y1073 What is Abeona Therapeutics's CUSIP number?
Abeona Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00431M308
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert